摘要
复杂、高危冠脉病变且有治疗指征的患者血运重建能改善预后,然而这类患者往往无法耐受冠脉搭桥手术,而倾向于选择经皮冠脉介入治疗,但其潜在的高风险却成为冠脉介入医生面临的一大挑战。近年来新药物、新器械及新技术的出现为这类患者接受冠脉介入治疗提供了更多保障,但其治疗策略仍然存在一定的争议。本文针对这一患者人群接受冠脉介入治疗的现状与进展作一综述。
Revascularization can improve the prognosis of patients with complex,high⁃risk coronary artery disease.However,the majority of the patients cannot tolerate coronary artery bypass surgery and prefer to choose percutaneous coronary intervention.The potential high risk has become a major challenge for coronary intervention⁃al physicians.In recent years,the new drugs,devices and technologies provide more guarantee for the interven⁃tion therapy,but it still remains controversial.This paper reviews the status and progress of coronary interventional therapy for the population with complex,high⁃risk coronary artery disease.
作者
马贵洲
徐荣和
蔡志雄
余丹青
MA Guizhou;XU Ronghe;CAI Zhixiong;YU Danqing(Department of Cardiology,Shantou Central Hospital,Shantou 515041,China;不详)
出处
《实用医学杂志》
CAS
北大核心
2021年第24期3107-3112,共6页
The Journal of Practical Medicine
基金
2019年汕头市第六批医疗卫生科技计划项目(编号:汕府科[2020]5号-8)。
关键词
复杂高危冠脉病变
经皮冠状动脉介入术
冠脉搭桥术
complex and high⁃risk coronary artery disease
percutaneous coronary intervention
coro⁃nary artery bypass
